Содержание

Слайд 2

Initial Laboratory Evaluation Complete blood count with indices: MCV – indication

Initial Laboratory Evaluation

Complete blood count with indices:
MCV – indication of

RBC size.
RDW – indication of RBC size variation.
Examination of the peripheral blood smear.
Reticulocyte count:
Measurement of newly produced young RBC’s.
Considered a measure of bone marrow responsiveness.
Слайд 3

Additional Labs Vitamin levels: iron profile, ferritin, Vitamin B12, folate. LDH,

Additional Labs

Vitamin levels: iron profile, ferritin, Vitamin B12, folate.
LDH, bilirubin,

haptoglobin.
Coomb’s test
Hemoglobin electrophoresis
SPEP
Creatinine
TSH
Urinalysis
Stool guaiac
Consider bone marrow examination
Слайд 4

Definition of Anemia Reduction in the volume of RBC’s (hematocrit) or

Definition of Anemia

Reduction in the volume of RBC’s (hematocrit) or concentration

(hemoglobin) when compared to similar values from a reference population.
Hgb = expression of amount (g/dL).
Hct = expression of volume (% or decimal fraction).
RBC = expression of number (#/mm3).
Слайд 5

Morphology Classification Microcytic (MCV Iron deficiency, thalassemia, chronic disease/inflammation, sideroblastic anemia,

Morphology Classification

Microcytic (MCV <80 µ3):
Iron deficiency, thalassemia, chronic disease/inflammation, sideroblastic

anemia, lead poisoning.
Normocytic (MCV 80-100 µ3):
Acute blood loss, chronic disease, hypersplenism, bone marrow failure, hemolysis.
Macrocytic (MCV >100 µ3):
B12 or folate deficiency, hemolysis with reticulocytosis, chemotherapy, hypothyroidism, MDS.
Слайд 6

Case 1 A 35 year old woman has a history of

Case 1

A 35 year old woman has a history of pleurisy

and has been told she may have SLE.
Previous CBC’s have been normal.
She presents to your office with complaints of exertional dyspnea, fatigue, and yellowing of her eyes.
Physical exam is normal except for mild scleral icterus and moderate splenomegaly.
Слайд 7

Case 1 Initial Labs: Hemoglobin 7.9 gm/dL HCT 23.9% WBC 4000/mm3

Case 1

Initial Labs:
Hemoglobin 7.9 gm/dL
HCT 23.9%
WBC 4000/mm3 with a normal

differential
Platelet 138,000/mm3
What other labs would you like to see?
Слайд 8

Case 1 MCV 114 Uncorrected Retic count 14.2% LDH 2343 U/L

Case 1

MCV 114
Uncorrected Retic count 14.2%
LDH 2343 U/L
Bilirubin 4.3mg/dL
Direct bili

.8mg/dL
The peripheral blood smear reveals macrovalocytes, polychromasia, and an occasional nucleated red blood cell.
Слайд 9

Case 1

Case 1

Слайд 10

Case 1 You suspect an autoimmune hemolytic anemia based on her

Case 1

You suspect an autoimmune hemolytic anemia based on her history,

Physical Exam, labs, and smear.
What further tests would you like to order?
Слайд 11

Case 1 Direct Coombs Test (AKA direct antiglobulin test): RBC’s are

Case 1

Direct Coombs Test (AKA direct antiglobulin test):
RBC’s are washed,

removing serum and then incubated with antihuman globulin (Coombs reagent).
This binds immunoglobulin or complement factors fixed on the RBC surface, causing agglutination and therefore a positive DAT.
Слайд 12

Case 1 Direct Coombs test results are as follows: DAT: Positive

Case 1

Direct Coombs test results are as follows:
DAT: Positive 3+
IgG:

Positive 3+
Complement: Negative
What type of autoantibody is this?
What conditions are typically associated with this type of antibody?
Слайд 13

Case 1 You diagnose a warm-antibody hemolytic anemia and suspect an

Case 1

You diagnose a warm-antibody hemolytic anemia and suspect an underlying

autoimmune disorder.
Etiology:
Idiopathic
Autoimmune
Lymphoproliferative Disorder
Viral
Immunodeficiency
Medications
Слайд 14

Case 1 You decide to avoid blood transfusion because of: The

Case 1

You decide to avoid blood transfusion because of:
The difficulties

in obtaining cross match compatible blood, AND
The expected short half life of transfused blood.
What treatment do you recommend?
Слайд 15

Case 1 Treatment: Prednisone Splenectomy Rituximab (monoclonal antibody) Immunosuppressive agents Cytoxan, imuran, cyclosporin Danazol Plasma exchange

Case 1

Treatment:
Prednisone
Splenectomy
Rituximab (monoclonal antibody)
Immunosuppressive agents
Cytoxan, imuran, cyclosporin
Danazol
Plasma exchange

Слайд 16

Case 1 You begin her on 60 mg Prednisone and she

Case 1

You begin her on 60 mg Prednisone and she has

a good response. Upon several attempts at tapering the prednisone she has a relapse with worsening of the hemolytic anemia.
You are concerned about the long term side effects of Prednisone, thus you send her for a procedure.
Слайд 17

Case 1 She responds well to splenectomy, but still requires very

Case 1

She responds well to splenectomy, but still requires very low

maintenance doses of Prednisone.
Over the years she occasionally requires higher doses of Prednisone when she is ill or has a lupus flare.
Слайд 18

Case 2 You are referred a pleasant 34 year old African

Case 2

You are referred a pleasant 34 year old African American

woman who has been known to have a mild microcytic anemia, which was picked up some years ago on routine blood work. She is entirely asymptomatic. She has been prescribed iron several times over the years without a response.
What data would you like to review?
Слайд 19

Case 2 Labs: HCT 31-34% Hgb 10.6-11.4gm/dL PLT 232-312K/mm3 WBC 6500-8000/mm3

Case 2

Labs:
HCT 31-34%
Hgb 10.6-11.4gm/dL
PLT 232-312K/mm3
WBC 6500-8000/mm3 with a normal differential
MCV

72-74 cubic microns
What is in your differential diagnosis?
Слайд 20

Case 2 Differential Diagnosis: Iron deficiency anemia Noncompliance, inadequate dosing, incorrect

Case 2

Differential Diagnosis:
Iron deficiency anemia
Noncompliance, inadequate dosing, incorrect formulation.
Beta

thalassemia
Alpha thalassemia
Anemia of chronic inflammation/disease
Sideroblastic anemia
Lead
What additional lab tests would you like to order?
Слайд 21

Case 2 Iron studies are normal. Chemistries, liver function tests, thyroid

Case 2

Iron studies are normal.
Chemistries, liver function tests, thyroid studies

are normal.
No history of lead exposure.
You ask to see a peripheral blood smear and one other study. What is it?
Слайд 22

Case 2

Case 2

Слайд 23

Case 2 ASH image bank

Case 2

ASH image bank

Слайд 24

Case 2 You also request a hemoglobin electrophoresis. Hgb A =

Case 2

You also request a hemoglobin electrophoresis.
Hgb A = 97.5%
Hgb

A2 = 2.1%
Hgb F = 0.6%
What is your diagnosis of exclusion?
Слайд 25

Case 2 Alpha thalassemia with a double gene deletion. No treatment

Case 2

Alpha thalassemia with a double gene deletion.
No treatment is

necessary.
Anemia is not progressive.
No other systemic problems.
Often mistaken for iron deficiency and treated with iron or for anemia of chronic disease.
Слайд 26

Case 3 A 32 year old previously healthy woman with no

Case 3

A 32 year old previously healthy woman with no prior

medical history presents to your office stating that she has felt “unwell” for the past month. In the past 3 days she has experienced fevers, a “rash” on her legs, weakness, and shortness of breath. She has been too weak to get out of bed the last 24 hours and has experienced spontaneous nose bleeds.
Слайд 27

Case 3 Physical exam confirms an ill appearing woman. T =

Case 3

Physical exam confirms an ill appearing woman.
T = 38.6,

pulse 122, BP 123/54
Dried blood in the nares, pale conjunctiva
Dried mucous membrane
Tachycardia and tachypnea
Petechiae over the lower extremities
Слайд 28

Case 3 Routine labs: WBC = 1700/mm3 Hgb = 5.6 gm/dL

Case 3

Routine labs:
WBC = 1700/mm3
Hgb = 5.6 gm/dL
HCT 18.2%
Platelet –

12,000/mm3
What important piece of laboratory information is missing from the WBC?
Слайд 29

Case 3 Differential of the white blood cell count reveals at

Case 3

Differential of the white blood cell count reveals at least

50% of young white cells, the lab thinks are blasts.
Reticulocyte count = 0.4%
Electrolytes are consistent with dehydration, potassium and creatinine are slightly elevated.
Слайд 30

Case 3

Case 3

Слайд 31

Case 3

Case 3

Слайд 32

Case 3

Case 3

Слайд 33

Case 3 Hematopathology evaluation revealed AML subtype M1. Chromosomal studies were

Case 3

Hematopathology evaluation revealed AML subtype M1.
Chromosomal studies were normal.


What should you do prior to beginning chemotherapy in this patient?
Слайд 34

Case 3 The patient tolerated induction chemotherapy well and remains in

Case 3

The patient tolerated induction chemotherapy well and remains in remission

4 months after completing induction and consolidation therapy. Her blood counts have all now normalized.
If she was to relapse what therapy would you recommend?
Слайд 35

Case 4 You are asked to see a 43 year old

Case 4

You are asked to see a 43 year old previously

healthy woman who presented to the ER complaining of fevers, weakness, and bleeding from her gums.
Her only significant past history is a recently resolved viral syndrome. Her family notes she has been somewhat confused over the last 24 hours.
Слайд 36

Case 4 The ER attending notes: The patient to be ill

Case 4

The ER attending notes:
The patient to be ill appearing
T

38.3, HR 123, BP 126/76, RR 26
Dried blood in the nares and mouth
Petechiae on lower extremities
Patient slightly confused, but no focal neurologic findings.
Before you arrive in the ER she has a seizure.
Слайд 37

Case 4 Labs: WBC 5600/mm3, normal differential HCT 16.3% Hgb 5.3

Case 4

Labs:
WBC 5600/mm3, normal differential
HCT 16.3%
Hgb 5.3 gm/dL
Platelets 21,000/mm3
PT 11

sec
PTT 29 sec
Слайд 38

Case 4 Labs: Creatinine 2.4 mg/dL LDH 3000 U/L Bili 3.2

Case 4

Labs:
Creatinine 2.4 mg/dL
LDH 3000 U/L
Bili 3.2 mg/dL, mostly indirect
Reticulocyte

count 6.2%
Haptoglobin <10mg/dL
Urine: 2+ hemoglobin, neg RBC
Слайд 39

Case 4

Case 4

Слайд 40

Case 4 What is your differential diagnosis based on the history,

Case 4

What is your differential diagnosis based on the history, physical,

labs and blood smear?
What else could give you a similar blood smear?
Слайд 41

Case 4 You diagnosis TTP based on the classic pentad and

Case 4

You diagnosis TTP based on the classic pentad and consistent

blood smear:
Microangiopathic hemolytic anemia
Thrombocytopenia
Fever
Renal Failure
MS changes
What is the first line treatment of TTP?
Слайд 42

Case 4 You begin daily plasma exchange procedures using FFP as

Case 4

You begin daily plasma exchange procedures using FFP as your

replacement fluid. Her mental status improves by the next day. Her platelet count normalizes and LDH decreases over the next week. Her anemia slowly improves as does her renal failure. She is weaned off plasma exchange and has a single relapse, which responds to similar therapy.
Слайд 43

Case 4 Pathophysiology: Typically an inhibitor against ADAMTS- 13, a vWF

Case 4

Pathophysiology:
Typically an inhibitor against ADAMTS- 13, a vWF cleaving

to protease leading to accumulation of High Molecular Weight vWF multimers leading to small vessel thrombosis and microangiopathic hemolytic anemia.
Plasmapheresis:
Removes the offending antibody
Supplies the deficient ADAMTS-13
Слайд 44

Case 4

Case 4

Слайд 45

Case 5 A 36 year old Caucasian man with a history

Case 5

A 36 year old Caucasian man with a history of

progressive renal failure over the last 4 years comes to you for work up of weakness and progressive anemia. He has recently begun dialysis. His renal failure initially appeared after an acute febrile illness and the etiology was never determined.
Слайд 46

Case 5 Physical exam is significant for pale sclera and an

Case 5

Physical exam is significant for pale sclera and an AV

shunt in his left arm.
CBC:
WBC 6400/mm3
Hgb 7.6 gm/dL
HCT 23.8%
Platelet 242,000/mm3
MCV 78/mm3
Слайд 47

Case 5 Prior labs reveal a hematocrit that was normal 4

Case 5

Prior labs reveal a hematocrit that was normal 4 years

ago, but has steadily declined as his renal function worsened.
Reticulocyte count corrected= 0.7%
Fe 26 mcg/dL
TIBC 224 mcg/dL
Iron saturation 11%
Ferritin 145 ng/mL
What is in your differential diagnosis?
Слайд 48

Case 5

Case 5

Слайд 49

Case 5 Differential Diagnosis: Anemia of renal failure Iron deficiency anemia

Case 5

Differential Diagnosis:
Anemia of renal failure
Iron deficiency anemia
Thalassemia
Lead poisoning
Myelodysplasia
Mixed microcytic

and macrocytic anemia.
You request one more study to support your suspicion?
Слайд 50

Case 5 You order an erythropoietin level which returns at 12

Case 5

You order an erythropoietin level which returns at 12 IU

( 4.1-19.5 ) within the normal limits.
What do you make of this value?
Should you proceed to a bone marrow exam?
Слайд 51

Case 5 You place the patient on 10,000 units of EPO

Case 5

You place the patient on 10,000 units of EPO SQ

tiw with dialysis. He comes to see you in one month feeling better.
Labs:
HCT 34%
Hgb 11.2 gm/dL
MCV 83/mm3
Retic 3.2%
Слайд 52

Case 5 He continues on his EPO injections for four months.

Case 5

He continues on his EPO injections for four months. Soon after

he again becomes fatigued, but otherwise doing well. Labs reveal:
WBC 6200/mm3
Hgb 8.9 gm/dL
Platelet 234,000/mm3
MCV 76 cubic microns
Retic .6%
Слайд 53

Case 5

Case 5

Слайд 54

Case 5 You suspect with his increased reticulocytosis and hgb/hct over

Case 5

You suspect with his increased reticulocytosis and hgb/hct over the

last few months he has become iron deficient. You confirm this with lab assay.
You give him 1 gram of intravenous iron and ask him to come back in 2 weeks.
Слайд 55

Case 5 He again feels much improved and is tolerating the

Case 5

He again feels much improved and is tolerating the iron

fairly well. His hematocrit has increased to 33%, corrected reticulocyte count to 3.2%, and the MCV is now 80 cubic microns.
He continues on Iron and EPO injections and is considering renal transplant.
Слайд 56

Case 5: Anemia of Chronic Inflammation Mild to moderate anemia that

Case 5: Anemia of Chronic Inflammation

Mild to moderate anemia that is

persistent for greater than 1-2 months in patients with infectious, inflammatory, or neoplastic diseases.
Other causes have been excluded.
Hypoproliferative, low reticulocyte count.
Normocytic-MCV 80-100:
May be microcytic in later stages.
Iron studies show low serum iron, low percent saturation, and normal to elevated ferritin.
Adequate reticuloendothelial iron stores.
Слайд 57

Case 5: Pathophysiology Epo production is inhibited or decreased, so inappropriately

Case 5: Pathophysiology

Epo production is inhibited or decreased, so inappropriately low

levels.
Increased levels of inflammatory cytokines:
IL-1, TNF α.
IL-6 causes induction of hepcidin synthesis (decreased iron absorption).
Alterations in iron metabolism.
Suppression of erythropoiesis.
Moderate decrease in RBC survival.
Слайд 58

Case 5: Laboratory Abnormalities ASH SAP 5th edition

Case 5: Laboratory Abnormalities

ASH SAP 5th edition

Слайд 59

Case 5 ACI does not usually require treatment. Iron replacement is

Case 5

ACI does not usually require treatment.
Iron replacement is typically

not necessary.
Erythrocyte-stimulating agent can be given in the setting of renal disease however caution regarding hypertension and thrombosis.
Treat the underlying cause!
Слайд 60

Case 6 A 53 year-old female complains of fatigue for 3

Case 6

A 53 year-old female complains of fatigue for 3 months.

She falls and breaks her left femur.
On reviewing her labs the creatinine is 1.3 mg/dl, calcium 10.1 mg/dL. Comprehensive metabolic panel is otherwise normal.
Hematocrit is 25%. White blood count and platelet counts are mildly depressed at 3.9K/mm3 and 147K/ mm3.
Слайд 61

Case 6 What is the most likely diagnosis? How do you

Case 6

What is the most likely diagnosis?
How do you want to

proceed with your evaluation?
Слайд 62

Case 6 Serum protein electrophoresis (SPEP) M- spike of 4.2 gm/dl

Case 6

Serum protein electrophoresis (SPEP)
M- spike of 4.2 gm/dl
Immunofixation (IFE)
IgG lambda

noted in serum.
Free lambda light chains in urine.
Quantitative immunoglobulins
Moderately suppressed levels of IgM (31 mg/dL) and IgA (32 mg/dL).
IgG elevated at 3875 mg/dL
Слайд 63

Case 6 Skeletal survey Multiple lytic lesions throughout the skeleton Bone

Case 6

Skeletal survey
Multiple lytic lesions throughout the skeleton
Bone Marrow aspirate and

biopsy
Sheets of malignant appearing plasma cells identified
Слайд 64

Case 6 An M-protein is usually seen as a discrete band

Case 6

An M-protein is usually seen as a discrete band on

agarose gel electrophoresis in the γ,β,α2 region of the densitometry tracing.
Immunoglobulins primarily in γ component, but also in β and α2 region
A polyclonal response produces a broad band or a broad-based peak limited to the γ region
Слайд 65

Case 6: SPEP

Case 6: SPEP

Слайд 66

Case 6: SPEP NORMAL

Case 6: SPEP

NORMAL

Слайд 67

Case 6: Myeloma + - α1 α2 β γ *

Case 6: Myeloma

+

-

α1

α2

β

γ

*

Слайд 68

Case 6: Density Scan + - Albumin α-1 α-2 β

Case 6: Density Scan

+

-

Albumin

α-1

α-2

β

Слайд 69

Case 6 When to order an SPEP: When you suspect multiple

Case 6

When to order an SPEP:
When you suspect multiple myeloma,

Waldenstrom’s macroglobulinemia or amyloidosis.
With unexplained:
Weakness, fatigue, anemia, back pain, fractures, hypercalcemia, renal insufficiency.
Recurrent infections.
Sensorimotor neuropathy, carpal tunnel syndrome, CHF, syncope.
Слайд 70

Case 6 Immunofixation (IFE): Proteins are fractioned on electrophoretic strips: Each

Case 6

Immunofixation (IFE):
Proteins are fractioned on electrophoretic strips:
Each lane overlaid

with monospecific antisera against IgG, IgA, IgM, and light chains
Immunoglobulins are precipitated by antisera
Wash away nonprecipitated proteins
Precipitated proteins are stained
Слайд 71

Case 6: Normal IFE gamma alpha mu kappa lambda SPE

Case 6: Normal IFE

gamma

alpha

mu

kappa

lambda

SPE

Слайд 72

Case 6 When to order an IFE: To type the paraprotein

Case 6

When to order an IFE:
To type the paraprotein (M

spike) identified on SPEP
Further evaluate an equivocal SPEP
To search for a low level paraprotein with a negative SPEP:
clinical suspicion of a lymphoplasmacytic disorder is high
unexplained symptoms such as neuropathy, renal failure, etc..
When searching for Bence-Jones proteinuria
In treated myeloma patients with a negative SPEP
Слайд 73

Case 6: Quantitative Immunoglobulins Useful to quantitate: The amount of monoclonal

Case 6: Quantitative Immunoglobulins

Useful to quantitate:
The amount of monoclonal protein
Suppression

of uninvolved immunoglobulins in a monoclonal disorder
Identify a congenital or acquired deficiency state of an individual immunoglobulin
Слайд 74

Case 6 Serum light chain assays are newer and a very

Case 6

Serum light chain assays are newer and a very sensitive

technique for measuring serum light chains.
Either an adjunct to or replacement of urine protein electrophoresis.
Слайд 75

Case 6: Quantitative Immunoglobulins + - Albumin “M-spike”, “Paraprotein” or “M-

Case 6: Quantitative Immunoglobulins

+

-

Albumin
“M-spike”, “Paraprotein” or “M-

α-1

α-2

β

Note loss of normal “polyclonal”

immunoglobulins

component”

Слайд 76

Case 6 Our patient

Case 6

Our patient

Слайд 77

Case 6

Case 6

Слайд 78

Case 6: Stage III Multiple Myeloma The patient is started on

Case 6: Stage III Multiple Myeloma

The patient is started on systemic

chemotherapy and an autologous bone marrow transplant is planned.
Multiple new and effective agents exist for MM:
Thalidomide or Revlimid and other anti-angiogenic agents.
Proteosome inhibitors (velcade)
Double autologous transplant
Mini allogeneic transplant
Remains non-curative except possibly for allogeneic transplant
Слайд 79

Case A A 45 yo white male presents to his physician

Case A

A 45 yo white male presents to his physician complaining

of tiredness and fatigue over the last several months. He is otherwise healthy. His only other complaint is vague abdominal discomfort. The only medications he takes are daily NSAIDS for a knee injury he sustained while playing tennis.
You are concerned he might be anemic. What questions should you ask in the H & P?
Слайд 80

Case A Progression of symptoms Blood in stool Other medications or

Case A

Progression of symptoms
Blood in stool
Other medications or toxins, including EToH
Prior

history of anemia, prior CBC’s
Other constitutional symptoms, recent illness
Family history
Diet
Craving ice, starch, or dirt
Слайд 81

Case A The patient does note he has had black tarry

Case A

The patient does note he has had black tarry stools

for a few weeks prior to his visit. You suspect GI blood loss induced by NSAID use.
What should you key in on the physical exam?
Слайд 82

Case A You order a CBC which shows the following results:

Case A

You order a CBC which shows the following results:
Hbg

8.2 gm/dL
HCT 26%
RBC count 3.82 million/mm3
MCV 73 cubic microns
Platelet count 516,000/mm3
WBC 7,000/mm3
What is your interpretation of these values?
Слайд 83

Case A

Case A

Слайд 84

Case A Iron studies: Fe 14 ug/dL TIBC 426 ug/dL %

Case A

Iron studies:
Fe 14 ug/dL
TIBC 426 ug/dL
% sat 3%
Ferritin 10ng/mL
Corrected

reticulocyte count 1.1%
Are any other studies (bone marrow) needed?
Слайд 85

Case A You confirm iron deficiency likely secondary to NSAID use.

Case A

You confirm iron deficiency likely secondary to NSAID use. An endoscopy

confirms a H.pylori negative ulcer with chronic bleeding. He is started on Omeprazole and his NSAID is stopped.
You prescribe oral Fe Sulfate 325 mg titrated to TID which he tolerates fairly well.
He comes back to see you in 4 weeks.
Слайд 86

Case A He feels much better and has experienced resolution of

Case A

He feels much better and has experienced resolution of his

fatigue and lethargy.
Hgb 12gm/dl
HCT 35%
MCV 82 cubic microns
Retic count 4.2%
Why do you think his retic count is elevated?
Can you stop his Fe sulfate when his hgb/hct become normal?
Слайд 87

Case A

Case A

Слайд 88

Case B A 67 year old woman with a history of

Case B

A 67 year old woman with a history of IDDM

and treated hypothyroidism is referred to you for evaluation of anemia. Her complaints leading to this diagnosis included weakness, fatigue, weight loss, and mild numbness in her feet bilaterally.
Physical exam was essentially normal except for mild loss of proprioception in her feet bilaterally.
Слайд 89

Case B Current Labs: 2 years ago: How do you interpret these values?

Case B

Current Labs:

2 years ago:

How do you interpret these values?


Слайд 90

Case B *Hypersegmented neutrophil, macroovalocytes

Case B

*Hypersegmented neutrophil, macroovalocytes

Слайд 91

Case B What tests or procedures do you want to perform to further evaluate this patient?

Case B

What tests or procedures do you want to perform to

further evaluate this patient?
Слайд 92

Case B You diagnose B12 deficiency and prescribe B12 injections 1000ug

Case B

You diagnose B12 deficiency and prescribe B12 injections 1000ug weekly

x4 then 1000ug a month indefinitely.
In 1 month the patient feels remarkably better and her blood counts have all improved.
Слайд 93

Case B: Vitamin B12 Deficiency Found primarily in animal meats. Large

Case B: Vitamin B12 Deficiency

Found primarily in animal meats.
Large hepatic

reservoir.
Deficiency from decreased oral intake takes many years.
In the duodenum cobalamin binds to intrinsic factor produced by parietal cells of the stomach.
In the terminal ileum, cobalamin-IF complex is transported through the enterocyte into the blood.
Almost always due to malabsorption:
Pernicious anemia, achlorhydria, IBD, celiac disease, pancreatic insufficiency, bacterial overgrowth, alcohol.
Слайд 94

Case B: Vitamin B12 Deficiency Clinical findings: Insidious onset. Glossitis, weight

Case B: Vitamin B12 Deficiency

Clinical findings:
Insidious onset.
Glossitis, weight loss, pale

yellow skin.
Neurologic manifestations:
Loss of position or vibratory sense.
Can progress to spastic ataxia.
May occur with mild anemia and may be irreversible.
Psychiatric disorders can occur without evidence of hematologic abnormalities.
Hallucinations, dementia, psychosis, “megaloblastic mania”.
May be irreversible.
Слайд 95

Case B: Vitamin B12 Deficiency Lab findings: Cobalamin If low-normal (200-350ng/L),

Case B: Vitamin B12 Deficiency

Lab findings:
Cobalamin <200ng/L.
If low-normal (200-350ng/L), check

homocysteine and MMA.
Both elevated in Vitamin B12 deficiency.
Methylmalonic acid level is more sensitive than low-normal cobalamin alone.
Pernicious anemia:
Autoantibodies to parietal cells or intrinsic factor (50-70% sensitive, 100% specific).